DSM logo — inactive - follow dsm-firmenich

DSM

inactive - follow dsm-firmenich

Founded 1902 The Netherlands The Netherlands 12087 employees IPO Biotechnology, Health Care +1

General Information

Company Name DSM
Founded Year 1902
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member Team member
Employees 12087
Industries Biotechnology, Health Care, Life Sciences
Funding Stage IPO
Business Model B2B, D2C
Revenue Model Product Sales, Licensing, Service Fee
Offices as of Oct 2026
Heerlen, The Netherlands Kaiseraugst, Switzerland Delft, The Netherlands Parsippany, United States Sao Paulo, Brazil
Social

BounceWatch is an independent company data service, not affiliated with DSM. To contact DSM, visit dsm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DSM compare?

A PDF of DSM and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DSM soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Homepage Update

Significant changes detected on company website (100% content change).

In The News Oct 10, 2026

Featured on De Belegger: Na de verkoop moet een kleiner dsm-firmenich meer verdienen

About DSM

DSM, founded in 1902, was a prominent player in the Biotechnology, Health Care, and Life Sciences industries until its significant merger in May 2023. This strategic move led to its integration into dsm-firmenich, marking a new era for the company's operations and focus.

Headquartered in The Netherlands, DSM has a storied history of contributing to innovative solutions across its core sectors. As of December 1, 2008, the company's noteworthy financial milestone was its IPO investment, which remains a pivotal point in its capital history. Currently, no detailed information about the investors involved in this IPO is available.

With the transition to dsm-firmenich, investors are encouraged to redirect their attention to this new entity. Those evaluating opportunities in biotechnology and life sciences should monitor dsm-firmenich's future initiatives, given DSM's established legacy and industry influence.

Business keywords: Life Sciences, Materials Sciences, Innovative Products, Human Nutrition, Animal Nutrition, Personal Care, Pharmaceuticals, Automotive Solutions, Coatings and Paint, Electrical and Electronics, Life Protection, Food Ingredients, Vitamins, Fragrances, Natural Ingredients

Services & Products

Development of microbiome-targeted solutions
Guidance on product innovation and clinical development
Education of healthcare providers and patients

Target Customers

Healthcare professionals Medical consultants Physicians specializing in gastroenterology and pediatrics Integrative medicine practitioners

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
IPO Undisclosed -
01 Dec 2008

DSM Alternatives & Competitors

View All Alternatives
DSM vs
Dollvet
Dollvet Turkey

Korumaya Değer!

196 employees
Biopharma, Biotechnology
DSM vs
Amgen
Amgen United States

#WeareBiotech

IPO
40947 employees
Biotechnology, Health Care
DSM vs

We are a synthetic biology company developing a platform to industrialize and scale the microbiome.

Seed
22 employees
AI, Biotechnology

FAQ About DSM

inactive - follow dsm-firmenich
DSM was founded in 1902.
DSM is headquartered in The Netherlands. As of Oct 2026, it also has offices in Heerlen, The Netherlands, Kaiseraugst, Switzerland, Delft, The Netherlands, Parsippany, United States and Sao Paulo, Brazil.
DSM operates in Biotechnology, Health Care and Life Sciences. Its work centres on Life Sciences, Materials Sciences, Innovative Products and Human Nutrition. Its customers include Healthcare professionals, Medical consultants and Physicians specializing in gastroenterology and pediatrics.
DSM has a B2B and D2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
DSM has approximately 12087 employees.
DSM has completed 1 funding round. The latest funding stage is IPO.
DSM offers: Development of microbiome-targeted solutions, Guidance on product innovation and clinical development, Education of healthcare providers and patients.
Top alternatives and competitors to DSM include Dollvet, Amgen, Persephone Biosciences, Boehringer Ingelheim, Advanced BioNutrition Corp.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DSM and Dollvet are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DSM, https://bouncewatch.com/company/dsm, updated 11 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes